Thomas S McHugh insider trades
Open-market stock purchases and sales by Thomas S McHugh, Chief Financial Officer at Avadel Pharmaceuticals plc, from SEC Form 4 filings since Jul 29, 2010.
Track record: 100% of 8 scored buys are up 5% or more since purchase, averaging +144%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $2.1M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $2.1M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $863K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $1.4M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $1.2M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $821K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $567K |